Evidence map›Paper›PMID 38550737›Full record

ArticleClinical case reports2024

Leukemia cutis revealing relapse of a chronic myeloid leukemia: A case report.

Amine Chérif, Mohammad Yassine Chérif, Anne-Laure Trépant, Anne-Pascale Meert, Maxime Ilzkovitz

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amine ChérifDepartment of Intensive Care and Oncological Emergencies & Thoracic Oncology, Institut Jules Bordet Université Libre de Bruxelles Brussels Belgium.
Mohammad Yassine ChérifDepartment of Rheumatology, Erasme University Hospital Université Libre de Bruxelles (ULB) Brussels Belgium.ORCID https://orcid.org/0000-0001-7926-1016
Anne-Laure TrépantDepartment of Pathology, Erasme University Hospital Université Libre de Bruxelles (ULB) Brussels Belgium.
Anne-Pascale MeertDepartment of Intensive Care and Oncological Emergencies & Thoracic Oncology, Institut Jules Bordet Université Libre de Bruxelles Brussels Belgium.
Maxime IlzkovitzDepartment of Intensive Care and Oncological Emergencies & Thoracic Oncology, Institut Jules Bordet Université Libre de Bruxelles Brussels Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: Clinical presentation of leukemia cutis (LC) is polymorphic and can reveal a malignant hemopathy. More commonly described in cases of acute myeloid leukemia (AML), LC can also occur in case of chronic myeloid leukemia (CML). Abstract: Leukemia cutis is a rare form of extramedullary feature of malignant hemopathy, seldom associated with CML. Its clinical presentation is pleiotropic and differential diagnosis is broad. It relies on clinical and typical histological and biomolecular concordance. Once confirmed, treatment is based on that of the primary condition. We present a case of a leukemia cutis revealing a relapse of a CML successfully treated by tyrosine kinase inhibitor.

Indexed as

chronic myeloid leukemia ‐ acute myeloid leukemiahematologyimmunologyleukemia cutismyeloproliferative syndrome

Identifiers

PMID38550737
PMCPMC10973095

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.